Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Bentley Systems Inc Projects Strong Financial Performance for Fiscal Year 2024

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Tokenized-security-technology
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Bentley Systems, Inc. is projecting a robust financial performance for the fiscal year 2024, with an expected revenue range of $1.350 billion to $1.375 billion and a constant currency growth of 10% to 12%. The company is also anticipating a constant currency ARR growth rate of 10.5% to 13%, an adjusted OI w/SBC margin annual improvement of approximately 100 basis points, an effective tax rate of around 20%, cash flow from operations representing a conversion rate from Adjusted EBITDA of about 80%, and capital expenditures of approximately $22 million.

Looking back at the full year 2023, Bentley Systems has adjusted its ARR growth outlook to a range of 12% to 13%, taking into account lower expectations for programmatic acquisition contributions and a shift in the business model.

Overall, Bentley Systems remains optimistic about its financial outlook for FY24, building on its past successes and strategic plans for the upcoming year.

BSY Stock Price Analysis: Strong Momentum and Positive Trends – February 27, 2024

On February 27, 2024, BSY stock showed strong price momentum as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well in the medium to long term.

The price of BSY shares increased by $0.31 since the market last closed, representing a 0.59% rise. This positive price change suggests that investors have been optimistic about the company’s prospects. However, it is important to note that the stock has since dropped by $0.44 in pre-market trading, which could indicate some volatility in the market.

As of the last close, BSY stock was priced at $52.49. Despite the drop in pre-market trading, the stock is still trading near its recent highs, which could be a positive sign for investors.

Overall, BSY stock has shown strong performance on February 27, 2024, with price momentum and a slight increase in share price. Investors should continue to monitor the stock’s performance and market trends to make informed decisions about their investments.

BSY Stock Shows Strong Performance with Impressive Revenue and Net Income Growth

On February 27, 2024, BSY stock showed strong performance based on the latest financial data provided by CNN Money. The company reported total revenue of $1.10 billion for the past year, which marked a 13.89% increase compared to the previous year. Additionally, the total revenue for the third quarter of the year was $306.61 million, showing a 3.32% increase from the previous quarter.

BSY reported a net income of $174.74 million for the past year, representing an impressive 87.52% increase compared to the previous year. The net income for the third quarter was $53.01 million, showing an 8.92% increase from the previous quarter.

Earnings per share (EPS) for BSY also showed significant growth, with a reported EPS of $0.53 for the past year, marking a 77.82% increase compared to the previous year. The EPS for the third quarter was $0.16, showing an 8.44% increase from the previous quarter.

Overall, the strong financial performance of BSY indicates that the company is on a positive trajectory and is experiencing growth in both revenue and net income. Investors may view these results as a positive sign of the company’s financial health and potential for future growth.

Tags: BSY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Sealed Air NYSE SEE Exceeds Analyst Expectations in Quarterly Earnings Despite YearOverYear Decrease

Renewable-energy

Delek US Holdings Reports Quarterly Loss and Strategic Initiatives for Future Growth

Apellis Pharmaceuticals Reports Quarterly Loss and Revenue Growth in Q4 2023

Recommended

Marvell Technology Stock

Marvell Technology Emerges as Key Player in AI Infrastructure Boom

1 month ago
Novo Nordisk Stock

Danish Pharma Giant Novo Nordisk Faces Diverging Analyst Views

1 month ago
Finance_Investment (5)

Anticipation Builds as FirstService Prepares to Release Quarterly Earnings Report

2 years ago
Viking Therapeutics Stock

Acquisition Speculation Fuels Viking Therapeutics Stock Surge

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

DuPont Faces Critical Test as Quarterly Results Loom

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

Trending

BioNTech Stock
Analysis

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

by Andreas Sommer
November 6, 2025
0

BioNTech presents investors with a complex financial picture marked by contradictory signals. The German biotech firm reported...

Illumina Stock

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

November 6, 2025
Iovance Stock

Iovance Faces Critical Test as Q3 Earnings Approach

November 6, 2025
DuPont de Nemours Stock

DuPont Faces Critical Test as Quarterly Results Loom

November 6, 2025
Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise
  • China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally
  • Iovance Faces Critical Test as Q3 Earnings Approach

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com